Skip to main content
Home
Latest news
Browse topics
Cardiovascular disorders Chronic kidney disease Diabetes devices & technology GLP-1 receptor agonists Hyperglycemia Hypoglycemia Obesity, diet, & lifestyle interventions SGLT2 inhibitors Type 1 diabetes Type 2 diabetes Browse all topics
EN
EN
In focus
Novel clinical evidence in continuous glucose monitoring Fasting for religion and health in people with diabetes The challenge of type 2 diabetes in children HFpEF & diabetes: Diagnosis and management in the wake of EMPEROR-Preserved Addressing suicide risk in diabetes: Rates and risk factors, HCP fears, and practical advice The SURPASS trials: Summarizing efficacy data on tirzepatide Semaglutide for weight loss: STEP and SELECT trials: Results from the STEP and SELECT trials Why psychosocial care matters DiRECT: Type 2 diabetes remission through weight management
Congress coverage
EASD 58th Annual Meeting 2022 The American Diabetes Association 82nd Scientific Sessions
About us
Medicine Matters Diabetes
EXTENDED SEARCH
25 search results for:

Insulin lispro 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 04-13-2018 | Insulin glargine | Review | Article

    A review of basal-bolus therapy using insulin glargine and insulin lispro in the management of diabetes mellitus

    This article reviews the current evidence concerning a widely used basal-bolus strategy combining insulin glargine 100 U/mL with insulin lispro in

  2. 06-28-2017 | Topic page

    Insulin lispro

  3. 06-15-2022 | Insulin | News | Article

    Liver-targeted insulin reduces hypoglycemic events

    Switching 1% of standard bolus insulin lispro to a liver-targeted formulation decreases hypoglycemic events without affecting glucose control, OPTI-1 study findings indicate.

    Author:
    Laura Cowen
    Published in:
    Diabetes Obes Metab 2022; doi:10.1111/dom.14761
  4. 06-05-2022 | ADA 2022 | News | Article

    ​​​​​​​Ultra-rapid lispro noninferior to standard version in children

    Ultra-rapid lispro gives equivalent overall glycemic control to standard lispro, and is significantly better for some postprandial measurements in children with type 1 diabetes, shows the PRONTO-Peds trial.

    Author:
    Eleanor McDermid
    Published in:
    ADA Scientific Sessions; New Orleans, Louisiana: 3–7 June 2022
  5. 06-04-2022 | ADA 2022 | News | Article

    Bionic pancreas removes math from diabetes

    The iLet bionic pancreas closed-loop insulin delivery system provides good glucose control without the need for the user to count carbohydrates, show findings from the pivotal trial.

    Author:
    Eleanor McDermid
    Published in:
    ADA Scientific Sessions; New Orleans, Louisiana: 3–7 June 2022
  6. 10-14-2020 | Tirzepatide | At a glance | Article
    Updated April 2023

    A quick guide to the SURPASS and SURMOUNT trials
    Phase 3 and 4 trials of tirzepatide in type 2 diabetes and obesity

    Related news story:  SURPASS-5: Glycemic, weight benefits of tirzepatide in insulin-dependent type 2 diabetes SURPASS-6: Completed, not yet published Trial population: People taking insulin glargine, with or without metformin Comparator treatment: Insulin lispro NCT04537923 SURPASS-6 is assessing tirzepatide as an alternative to starting a prandial insulin in people already using a basal insulin to treat type 2 diabetes.

    Author:
    Eleanor McDermid
  7. 04-26-2022 | Ketoacidosis | News | Article

    Subcutaneous insulin protocol feasible for DKA

    Implementing a subcutaneous insulin protocol for the treatment of diabetic ketoacidosis significantly reduces intensive care admissions and readmission to hospital within 30 days of discharge without increasing hypoglycemia, research shows.

    Author:
    Laura Cowen
    Published in:
    JAMA Netw Open 2022; 5 : e226417
  8. 04-08-2022 | Insulin | News | Article

    Pivotal study shows feasibility of extended-wear insulin infusion set

    An extended-wear insulin infusion set, worn for up to 7 days, is more satisfactory to users than standard insulin infusion sets and does not adversely affect glycemic control, shows a study in people with type 1 diabetes.

    Author:
    Laura Cowen
    Published in:
    Diabetes Technol Ther 2022; doi:10.1089/dia.2021.0540
  9. 02-07-2022 | Dulaglutide | At a glance | Article

    A quick guide to the AWARD trials

    AWARD-4: Published Trial population: People with insulin-treated type 2 diabetes Comparator treatment: Insulin glargine NCT01191268 All 884 participants of the AWARD-4 trial used a prandial insulin (lispro) but were randomly assigned to either continue basal insulin (glargine; treat to target) or replace it with dulaglutide.

    Author:
    Eleanor McDermid
  10. 05-20-2022 | Hyperglycemia | View from the clinic | Article

    Managing hyperglycemia in the face of a high-carbohydrate diet

    In insulin-requiring persons, postprandial control can be achieved by using ultra-rapid-acting insulin analogues (Fiasp/faster aspart, Lyumjev/lispro-aabc).

    Author:
    Sanjay Kalra
  11. 09-06-2017 | Healthcare costs | View from the clinic | Article

    The rising cost of medication: Groceries or insulin?

    He has been taking 15 different medications to stabilize these conditions, including insulin lispro and detemir.

    Author:
    Allison Petznick
  12. 06-27-2018 | Hyperglycemia | Article

    Contribution of BHG and PPHG to overall hyperglycemia in T2DM patients treated with LM25 and LM50: Post hoc analysis of a randomized crossover trial

    Li W et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0462-9

  13. 05-03-2018 | Pregnancy | Review | Article

    Pharmacotherapy for hyperglycemia in pregnancy: The new insulins

    Toledano Y, Hadar E, Hod M.  Diabetes Res Clin Prac 2018; Advance online publication. doi: 10.1016/j.diabres.2018.04.035

  14. 11-07-2017 | Premixed insulins | Review | Article

    Use of 50/50 premixed insulin analogs in type 2 diabetes: Systematic review and clinical recommendations

    Premixed insulin analogs represent an alternative to basal or basal–bolus insulin regimens for the treatment of type 2 diabetes (T2D).

  15. 06-18-2018 | Dulaglutide | News | Article

    Dulaglutide feasible alternative to insulin glargine in patients with CKD

    Once-weekly dulaglutide lowers glycated hemoglobin levels to a similar degree to titrated daily insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease, study findings indicate.

    Published in:
    Lancet Diabetes Endocrinol 2018; Advance online publication
  16. 11-03-2018 | Premixed insulins | Review | Article

    Expert opinion: Patient selection for premixed insulin formulations in diabetes care

    Kalra S et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0521-2

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.